-
1 Comment
Softmax Co., Ltd is currently in a long term uptrend where the price is trading 1.7% above its 200 day moving average.
From a valuation standpoint, the stock is 97.6% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 1.7.
Softmax Co., Ltd's total revenue sank by 11.9% to $1B since the same quarter in the previous year.
Its net income has increased by 91.0% to $185M since the same quarter in the previous year.
Based on the above factors, Softmax Co., Ltd gets an overall score of 3/5.
| Sector | Healthcare |
|---|---|
| Industry | Health Information Services |
| Exchange | TSE |
| CurrencyCode | JPY |
| ISIN | JP3436140002 |
| Market Cap | 5B |
|---|---|
| Beta | 0.5 |
| PE Ratio | 11.18 |
| Target Price | None |
| Dividend Yield | 6.5% |
Softmax Co., Ltd engages in the development, sale, implementation, and maintenance of medical information and corporate systems in Japan. The company offers web based electronic medical record system, web-based ordering system, medical accounting system, radiology information system, rehabilitation department system, health checkup system, nursing work management system, solution system, and surgical department system. Softmax Co., Ltd was incorporated in 1974 and is headquartered in Tokyo, Japan.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 3671.TSE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
